Let cost effectiveness models be open to scrutiny - Wikidata - awgldk - TriplyDB

Let cost effectiveness models be open to scrutiny

Let cost effectiveness models be open to scrutiny

http://www.wikidata.org/entity/Q42566217

about

Benefits, Challenges and Potential Strategies of Open Source Health Economic Models

P2860

Q42334579-76B477D3-35D0-424E-888A-5CDB0A1850C8

P2860

Let cost effectiveness models be open to scrutiny

http://www.wikidata.org/entity/Q42566217

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Let cost effectiveness models be open to scrutiny

@en

Let cost effectiveness models be open to scrutiny

@nl

type

label

Let cost effectiveness models be open to scrutiny

@en

Let cost effectiveness models be open to scrutiny

@nl

prefLabel

Let cost effectiveness models be open to scrutiny

@en

Let cost effectiveness models be open to scrutiny

@nl

P1433

Q42566217-D1BC6033-CF7D-4B3D-B086-22B473B80777

P1476

Q42566217-2993A956-37D6-463B-8088-E8E585A2C4B6

P2093

Q42566217-59C362AF-D5F4-460C-833A-9161B5863FB7

Q42566217-885A3585-2E3E-4931-980F-57F7FC52D114

Q42566217-B7EEABA7-5837-44D6-81D8-DD833DED6B2B

P2860

Q42566217-29DD7357-22A5-4D17-AB51-823AF59F3A64

Q42566217-4185A3B6-5DC2-4B15-9F0D-D129D7651C3A

Q42566217-53F32C67-2A9D-4EAF-AE3F-BACCC73F3F23

P304

Q42566217-38843EAD-23E3-4107-B201-CBD168193F4A

P31

Q42566217-1BCDA1D9-9E9B-4678-B3D2-D5F4AE6D63C6

P356

Q42566217-6FCB7677-DAB8-4BB2-A516-0D7D19B295F5

P407

Q42566217-44CD89EC-294A-413E-905C-2C6D26B9E6E0

P433

Q42566217-2D85E585-2F0F-499B-A8F7-01BA8CD103CD

P478

Q42566217-B8262508-5B5C-48AB-88F3-2A602E91EA80

P577

Q42566217-30429655-B1BE-4908-BAAB-FC61F8B47884

P5875

Q42566217-29100C08-C0BE-49C7-8489-711089FD86E0

P698

Q42566217-96F0A205-0165-4685-B24E-C46E24769794

P932

Q42566217-AFBB5316-0777-4400-B6B6-65D5D4A079DB

P356

BMJ.39360.379664.BE

P1433

P1476

Let cost effectiveness models be open to scrutiny

@en

P2093

Chris Poole

http://www.w3.org/2001/XMLSchema#string

Craig J Currie

http://www.w3.org/2001/XMLSchema#string

Samir Agrawal

http://www.w3.org/2001/XMLSchema#string

P2860

Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis

Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis.

Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting.

P304

735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.39360.379664.BE

http://www.w3.org/2001/XMLSchema#string

P407

P433

7623

http://www.w3.org/2001/XMLSchema#string

P478

335

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5913401

http://www.w3.org/2001/XMLSchema#string

P698

17932167

http://www.w3.org/2001/XMLSchema#string

P932

2018758

http://www.w3.org/2001/XMLSchema#string